#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	290	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1198	18.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	341	343	ACG	21;20;21	A;C;G	20;19;20	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1265	1267	AGC	25;25;25	A,G;G;C	17,8;25;24	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	1	SNP	p	R234F	1	.	.	700	702	TTC	740	742	TTC	68;68;69	T;T;C	67;66;68	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1040	1042	CGT	71;74;75	C;G;T	71;74;75	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	0	HET	.	.	.	T90C	.	90	90	T	130	130	T	41	T,C	26,15	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	0	HET	.	.	.	T123A	.	123	123	T	163	163	T	42	T,A	26,16	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	0	HET	.	.	.	T126G	.	126	126	T	166	166	T	42	T,G	26,16	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	0	HET	.	.	.	C261T	.	261	261	C	301	301	C	63	C,T	31,32	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	0	HET	.	.	.	T999C	.	999	999	T	1039	1039	T	70	T,C	42,28	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	0	HET	.	.	.	C144T	.	144	144	C	184	184	C	33	C,T	20,13	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	0	HET	.	.	.	C114T	.	114	114	C	154	154	C	43	C,T	28,15	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1016	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	49.2	0	HET	.	.	.	T180C	.	180	180	T	220	220	T	37	T,C	27,10	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	514	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1818	21.2	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1638	1640	AAA	13;13;12	A;A;A	13;13;12	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	610	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1922	23.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1341	1343	GAA	40;40;38	G;A;A	40;40;38	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	128	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	918	10.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Klebsiella_OmpK36_conferring.3003968.NC_016845.1.3727881_3728985.3765	Klebsiella_OmpK36_conferring.3003968.NC_016845.1.3727881_3728985.3765	1	0	528	26	Klebsiella_OmpK36_conferring	1104	144	91.67	Klebsiella_OmpK36_conferring.l15.c4.ctg.1	171	3.1	0	.	p	.	0	I24V	NONSYN	70	72	ATT	87	89	GTT	3;3;1	G;T;T	3;3;1	.	Klebsiella OmpK36 conferring resistance to beta-lactam;Klebsiella outer membrane porin protein. In beta-lactam-resistant Klebsiella, this porin is often deleted, limiting diffusion of the antibiotic into the cell. Klebsiella strains expressing OmpK36 are often beta-lactam sensitive even in the presence of beta-lactamases because of an inefficient mechanism.
Klebsiella_OmpK36_conferring.3003968.NC_016845.1.3727881_3728985.3765	Klebsiella_OmpK36_conferring.3003968.NC_016845.1.3727881_3728985.3765	1	0	528	26	Klebsiella_OmpK36_conferring	1104	144	91.67	Klebsiella_OmpK36_conferring.l15.c4.ctg.1	171	3.1	0	.	p	.	0	I38V	NONSYN	112	114	ATT	129	131	GTA	1;1;1	G;T;A	1;1;1	.	Klebsiella OmpK36 conferring resistance to beta-lactam;Klebsiella outer membrane porin protein. In beta-lactam-resistant Klebsiella, this porin is often deleted, limiting diffusion of the antibiotic into the cell. Klebsiella strains expressing OmpK36 are often beta-lactam sensitive even in the presence of beta-lactamases because of an inefficient mechanism.
Klebsiella_OmpK36_conferring.3003968.NC_016845.1.3727881_3728985.3765	Klebsiella_OmpK36_conferring.3003968.NC_016845.1.3727881_3728985.3765	1	0	528	26	Klebsiella_OmpK36_conferring	1104	144	91.67	Klebsiella_OmpK36_conferring.l15.c4.ctg.1	171	3.1	0	.	p	.	0	D47N	NONSYN	139	141	GAC	156	158	AAC	1;1;1	A;A;C	1;1;1	.	Klebsiella OmpK36 conferring resistance to beta-lactam;Klebsiella outer membrane porin protein. In beta-lactam-resistant Klebsiella, this porin is often deleted, limiting diffusion of the antibiotic into the cell. Klebsiella strains expressing OmpK36 are often beta-lactam sensitive even in the presence of beta-lactamases because of an inefficient mechanism.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	113	G	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	113	C	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	120	C	120	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	163	T	163	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	153	C	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	118	C	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	106	A	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	105	A	105	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	100	A	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	96	T	95	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	93	C	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	99	C	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	98	A	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	101	G	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	100	C	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	110	T	110	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	122	G	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	128	G	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	126	T	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	161	T	159	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	161	G	159	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	158	C,G	154,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	151	A	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	100	C	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	91	C	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	72	A	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	74	A	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	69	G	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	66	C	66	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	77	T	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	83	G	82	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	65	T	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	118.2	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	169	C	169	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	C990G	SNP	990	990	C	46	46	G	15	G	15	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	T1002A	SNP	1002	1002	T	58	58	A	16	A	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	A1003C	SNP	1003	1003	A	59	59	C	16	C	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	G1008C	SNP	1008	1008	G	64	64	C	16	C	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	C1011T	SNP	1011	1011	C	67	67	T	17	T	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	T1012C	SNP	1012	1012	T	68	68	C	17	C	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	C1023A	SNP	1023	1023	C	78	78	A	16	A	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	.1025G	INS	1025	1025	T	81	81	G	16	G	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	T1041G	SNP	1041	1041	T	97	97	G	17	G	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	171	91.86	Pasteurella_multocida_16S.l15.c17.ctg.3	171	13.4	0	.	n	.	0	A1042T	SNP	1042	1042	A	98	98	T	17	T	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.6	187	59.0	0	.	n	.	0	C990G	SNP	990	990	C	62	62	G	56	G	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.6	187	59.0	0	.	n	.	0	T1002A	SNP	1002	1002	T	74	74	A	41	A	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.6	187	59.0	0	.	n	.	0	A1004G	SNP	1004	1004	A	76	76	G	37	G,A	32,4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.6	187	59.0	0	.	n	.	0	C1011T	SNP	1011	1011	C	83	83	T	31	T	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.6	187	59.0	0	.	n	.	0	C1023A	SNP	1023	1023	C	95	95	A	41	A	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.6	187	59.0	0	.	n	.	0	T1024A	SNP	1024	1024	T	96	96	A	45	A	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.6	187	59.0	0	.	n	.	0	T1041G	SNP	1041	1041	T	113	113	G	60	G	60	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1786	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.6	187	59.0	0	.	n	.	0	A1042T	SNP	1042	1042	A	114	114	T	60	T	60	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	464	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1615	21.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	250	252	CGT	21;21;21	C;G;T	21;21;21	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	464	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1615	21.6	0	.	p	.	0	V30I	NONSYN	88	90	GTC	334	336	ATC	23;23;23	A,G;T;C	22,1;23;23	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	464	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1615	21.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1093	1095	GGC	34;34;34	G;G;C	33;34;34	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	666	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2095	23.8	0	.	p	.	0	R8S	NONSYN	22	24	AGA	259	261	AGC	20;21;23	A;G;C	20;21;23	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	666	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2095	23.8	0	.	p	.	0	I142L	NONSYN	424	426	ATA	661	663	CTA	21;19;21	C;T;A	21;19;20	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	666	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2095	23.8	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1180	1182	CAA	34;35;35	C;A;A	34;35;35	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	666	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2095	23.8	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1279	1281	GGT	40;40;41	G;G;T	40;40;41	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	666	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2095	23.8	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1849	1851	GTT	27;28;27	G;T;T	27;28;27	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	256	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1525	12.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	540	542	GAA	10;10;10	G;A;A	10;10;10	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	256	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1525	12.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	720	722	ACC	14;11;11	A;C;C	14;11;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	256	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1525	12.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	840	842	ACT	17;17;17	A;C;T	17;17;17	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	256	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1525	12.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1230	1232	ATC	7;7;7	A;T;C	6;6;6	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	450	PmrF	969	969	99.38	PmrF.l6.c4.ctg.1	1587	21.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1336	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3638	27.6	0	.	p	.	0	T85I	NONSYN	253	255	ACC	539	541	ATC	29;29;28	A;T;C	28;28;27	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1336	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3638	27.6	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2252	2254	AAG	33;31;32	A;A;G	33;29;32	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	436	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1728	19.1	0	.	p	.	0	A22V	NONSYN	64	66	GCC	335	337	GTC	23;23;22	G;T;C	23;23;22	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	436	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1728	19.1	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1076	1078	TGC	23;24;25	T;G;C	23;24;25	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1076	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3249	24.9	0	.	p	.	0	S46trunc	TRUNC	136	136	T	468	468	T	19	T	19	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1076	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3249	24.9	0	.	p	.	0	G148D	NONSYN	442	444	GGC	774	776	GAC	34;32;33	G;A;C	34;32;33	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1076	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3249	24.9	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1050	1052	TTA	21;20;20	T;T;A	21;20;20	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1076	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3249	24.9	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1233	1235	AAT	23;23;23	A;A;T	23;23;23	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1076	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3249	24.9	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	2020	2020	T	33	T	32	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	236	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1244	14.4	1	SNP	p	R45C	0	.	.	133	135	CGC	456	458	CGC	21;21;22	C;G;C	21;21;22	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	248	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1190	15.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	328	330	TTC	24;24;24	T;T;C	24;24;24	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	248	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1190	15.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	592	594	GGG	29;29;28	G;G;G	29;29;28	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	250	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1150	16.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	585	587	CTT	27;27;27	C;T;T	27;27;27	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1016	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3236	23.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2204	2206	GCA	27;26;26	G;C;A	27;26;25	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1016	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3236	23.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2465	2467	ACC	34;34;35	A;C;C	33;34;34	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1016	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3236	23.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2774	2776	GCC	29;29;30	G;C;C	29;29;30	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	642	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2565	18.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	410	412	GCT	16;17;18	G;C;T	16;17;18	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	642	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2565	18.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	530	532	GAG	18;18;19	G;A;G	18;18;19	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	642	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2565	18.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	566	568	TGC	15;16;16	T;G;C	15;16;16	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	642	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2565	18.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	749	751	GTT	28;28;28	G;T;T	27;27;27	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	642	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2565	18.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	899	901	CAC	26;26;25	C;A;C	26;26;25	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	642	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2565	18.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1184	1186	ATG	35;35;33	A;T;G	35;34;33	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	642	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2565	18.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2180	2182	CGC	33;33;31	C;G;C	33;33;31	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	310	bacA	822	806	98.64	bacA.l15.c30.ctg.1	915	23.7	0	.	p	.	0	S221T	NONSYN	661	663	AGC	767	769	ACC	18;18;18	A;C;C	18;18;18	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	310	bacA	822	806	98.64	bacA.l15.c30.ctg.1	915	23.7	0	.	p	.	0	P225S	NONSYN	673	675	CCG	779	781	TCG	19;19;17	T;C;G	19;19;17	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	284	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1344	15.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	432	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1931	16.8	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1337	1339	AAA	15;16;16	A;A;A	15;15;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	432	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1931	16.8	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1349	1351	GAG	17;17;17	G;A;G	17;17;16	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	432	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1931	16.8	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1355	1357	CAC	17;17;17	C;A;C	16;17;16	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	432	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1931	16.8	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1409	1411	GAG	8;9;9	G;A;G	8;9;9	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	548	cpxA	1374	1374	98.91	cpxA.l6.c4.ctg.1	1898	21.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	539	380	cpxR	699	699	99.28	cpxR.l15.c4.ctg.1	1281	22.3	0	.	p	.	0	E91D	NONSYN	271	273	GAG	645	647	GAT	42;41;41	G;A;T,G	42;41;40,1	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	308	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1326	17.5	0	.	p	.	0	A146T	NONSYN	436	438	GCT	640	642	ACT	24;25;26	A;C;T	23;24;25	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	136	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	936	10.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	394	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1451	20.2	0	.	p	.	0	I219V	NONSYN	655	657	ATC	745	747	GTC	28;29;29	G;T;C	27;28;29	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	590	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2006	22.0	0	.	p	.	0	E197K	NONSYN	589	591	GAA	871	873	AAA	29;29;27	A;A;A	29;29;27	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	520	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1578	24.7	0	.	p	.	0	G209S	NONSYN	625	627	GGC	781	783	AGC	32;31;29	A;G;C	32;31;29	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	18	emrE_1	333	103	96.12	emrE_1.l15.c4.ctg.2	124	5.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	268	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1570	12.7	0	.	p	.	0	K176R	NONSYN	526	528	AAG	812	814	AGG	17;17;16	A;G;G	17;17;16	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	268	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1570	12.7	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1202	1204	GAC	10;9;9	G;A;C	10;9;9	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	222	emrR	531	531	100.0	emrR.l15.c4.ctg.1	1024	15.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	452	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2061	16.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	138	evgA	615	615	99.19	evgA.l15.c4.ctg.1	995	10.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	383	385	CTG	17;17;17	C;T;G	17;17;17	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	T38I	NONSYN	112	114	ACA	263	265	ATA	6;6;6	A;T;A	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	L42V	NONSYN	124	126	CTA	275	277	GTA	7;7;8	G;T;A	7;7;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	428	430	ACG	21;21;20	A;C;G	21;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	491	493	GAA	25;25;26	G;A;A	25;25;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	530	532	GCT	22;22;22	G;C;T	22;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	548	550	GAT	18;19;19	G;A;T	18;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	635	637	TCA	23;23;23	T;C;A	22;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	764	766	CAG	24;23;25	C;A;G	24;23;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	902	904	GTT	15;15;14	G;T;T	15;15;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1058	1060	GAT	8;8;8	G;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1226	1228	AAT	11;11;11	A;A;T	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1247	1249	TTA	8;8;8	T;T;A	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1448	1450	AAA	11;11;10	A;A;A	11;11;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2183	2185	CAT	12;11;13	C;A;T	12;11;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2237	2239	CAT	13;13;13	C;A;T	12;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2255	2257	AGA	15;15;16	A;G;A	15;15;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2270	2272	AAT	19;19;19	A;A;T	19;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2417	2419	TCC	17;16;15	T;C;C	17;16;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2582	2584	ATT	17;16;16	A;T;T	17;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2603	2605	GAT	13;13;13	G;A;T	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2717	2719	GTT	12;12;11	G;T;T	12;12;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	858	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4027	16.1	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3002	3004	CAC	32;32;32	C;A;C	32;32;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	370	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1272	21.5	1	SNP	p	P64A	0	.	.	190	192	CCA	373	375	CCA	38;38;39	C;C;A	38;38;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	370	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1272	21.5	1	SNP	p	P64L	0	.	.	190	192	CCA	373	375	CCA	38;38;39	C;C;A	38;38;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	370	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1272	21.5	1	SNP	p	P64H	0	.	.	190	192	CCA	373	375	CCA	38;38;39	C;C;A	38;38;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	370	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1272	21.5	1	SNP	p	P64R	0	.	.	190	192	CCA	373	375	CCA	38;38;39	C;C;A	38;38;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	370	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1272	21.5	1	SNP	p	P64S	0	.	.	190	192	CCA	373	375	CCA	38;38;39	C;C;A	38;38;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	134	gadE	528	528	100.0	gadE.l15.c17.ctg.1	1051	8.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	62	gadW	729	507	94.48	gadW.l15.c17.ctg.1	615	6.6	0	.	p	.	0	I88M	NONSYN	262	264	ATA	42	44	ATG	2;2;2	A;T;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	62	gadW	729	507	94.48	gadW.l15.c17.ctg.1	615	6.6	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	45	47	CCG	2;2;2	C;C;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	62	gadW	729	507	94.48	gadW.l15.c17.ctg.1	615	6.6	0	.	p	.	0	D100E	NONSYN	298	300	GAC	78	80	GAA	3;3;3	G;A;A	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	62	gadW	729	507	94.48	gadW.l15.c17.ctg.1	615	6.6	0	.	p	.	0	P101S	NONSYN	301	303	CCC	81	83	TCC	3;2;2	T;C;C	3;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	62	gadW	729	507	94.48	gadW.l15.c17.ctg.1	615	6.6	0	.	p	.	0	R102G	NONSYN	304	306	CGG	84	86	GGG	2;2;2	G;G;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	62	gadW	729	507	94.48	gadW.l15.c17.ctg.1	615	6.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	108	110	AAT	3;3;3	A;A;T	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	62	gadW	729	507	94.48	gadW.l15.c17.ctg.1	615	6.6	0	.	p	.	0	S234A	NONSYN	700	702	TCG	480	482	GCG	3;3;3	G;C;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	184	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1283	10.8	0	.	p	.	0	F53L	NONSYN	157	159	TTC	391	393	TTA	7;7;6	T;T;A	7;7;6	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	184	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1283	10.8	0	.	p	.	0	V79I	NONSYN	235	237	GTT	469	471	ATT	12;12;11	A;T;T	12;11;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	184	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1283	10.8	0	.	p	.	0	R246G	NONSYN	736	738	AGA	970	972	GGA	14;13;14	G;G;A	14;13;14	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	184	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1283	10.8	0	.	p	.	0	S248P	NONSYN	742	744	TCG	976	978	CCG	17;17;17	C;C;G	17;17;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1112	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3250	25.6	1	SNP	p	S83L	1	S83L	NONSYN	247	249	TCG	550	552	TTG	28;28;28	T;T;G	28;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1112	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3250	25.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2335	2337	GAA	34;34;34	G;A;A	34;33;34	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1112	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3250	25.6	1	SNP	p	D87G	0	.	.	259	261	GAC	562	564	GAC	28;28;29	G;A;C	27;27;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1112	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3250	25.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	562	564	GAC	28;28;29	G;A;C	27;27;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1112	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3250	25.6	1	SNP	p	D87N	0	.	.	259	261	GAC	562	564	GAC	28;28;29	G;A;C	27;27;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1112	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3250	25.6	1	SNP	p	D87H	0	.	.	259	261	GAC	562	564	GAC	28;28;29	G;A;C	27;27;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1112	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3250	25.6	1	SNP	p	D87V	0	.	.	259	261	GAC	562	564	GAC	28;28;29	G;A;C	27;27;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	924	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2861	24.3	1	SNP	p	R136L	0	.	.	406	408	CGC	594	596	CGC	24;24;22	C;G;C	24;24;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	924	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2861	24.3	1	SNP	p	R136I	0	.	.	406	408	CGC	594	596	CGC	24;24;22	C;G;C	24;24;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	924	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2861	24.3	1	SNP	p	R136C	0	.	.	406	408	CGC	594	596	CGC	24;24;22	C;G;C	24;24;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	924	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2861	24.3	1	SNP	p	R136H	0	.	.	406	408	CGC	594	596	CGC	24;24;22	C;G;C	24;24;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	924	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2861	24.3	1	SNP	p	R136S	0	.	.	406	408	CGC	594	596	CGC	24;24;22	C;G;C	24;24;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	924	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2861	24.3	1	SNP	p	R136G	0	.	.	406	408	CGC	594	596	CGC	24;24;22	C;G;C	24;24;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	924	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2861	24.3	1	SNP	p	R136E	0	.	.	406	408	CGC	594	596	CGC	24;24;22	C;G;C	24;24;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	214	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	969	16.0	0	.	p	.	0	A72P	NONSYN	214	216	GCG	390	392	CCG	23;23;24	C;C;G	23;22;24	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	214	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	969	16.0	0	.	p	.	0	T123A	NONSYN	367	369	ACC	543	545	GCC	24;23;23	G;C;C,A	24;23;22,1	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	272	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1334	15.2	0	.	p	.	0	P9S	NONSYN	25	27	CCA	208	210	TCA	15;14;15	T;C;A	15;14;15	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	168	marA	384	384	99.74	marA.l15.c4.ctg.1	929	13.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	462	464	AGC	11;11;11	A;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	564	566	CAT	8;8;8	C;A;T	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	V45E	0	.	.	133	135	GTG	288	290	GTG	14;14;13	G;T;G	14;14;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	I49S	0	.	.	145	147	ATC	300	302	ATC	14;14;13	A;T;C	14;14;13	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	A70T	0	.	.	208	210	GCA	363	365	GCA	18;18;18	G;C;A	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	R73S	0	.	.	217	219	CGT	372	374	CGT	19;19;19	C;G;T	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	R73C	0	.	.	217	219	CGT	372	374	CGT	19;19;19	C;G;T	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	R77C	0	.	.	229	231	CGC	384	386	CGC	20;20;20	C;G;C	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	R77L	0	.	.	229	231	CGC	384	386	CGC	20;20;20	C;G;C	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	L78M	0	.	.	232	234	CTG	387	389	CTG	20;20;19	C;T;G	20;20;19	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	R94H	0	.	.	280	282	CGC	435	437	CGC	15;16;16	C;G;C	15;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	R94S	0	.	.	280	282	CGC	435	437	CGC	15;16;16	C;G;C	15;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	116	marR	435	435	97.7	marR.l15.c4.ctg.1	804	10.7	1	SNP	p	V96E	0	.	.	286	288	GTA	441	443	GTA	17;17;17	G;T;A	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	S7F	NONSYN	19	21	TCC	178	180	TTC	8;9;9	T;T;C	8;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	R36I	NONSYN	106	108	AGG	265	267	ATC	7;9;8	A;T;C	7;9;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	E42A	NONSYN	124	126	GAA	283	285	GCC	9;9;10	G;C;C	9;9;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	N43V	NONSYN	127	129	AAT	286	288	GTG	10;12;12	G;T;G	10;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	E52D	NONSYN	154	156	GAG	313	315	GAT	13;13;13	G;A;T	13;13;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	N59T	NONSYN	175	177	AAC	334	336	ACC	14;14;14	A;C;C	14;14;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	I68L	NONSYN	202	204	ATA	361	363	TTA	15;15;13	T;T;A,C	15;15;12,1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	502	504	CAG	25;25;25	C;A;G	25;24;25	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	D128A	NONSYN	382	384	GAC	541	543	GCC	19;20;20	G;C;C	19;20;20	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	S163A	NONSYN	487	489	TCG	646	648	GCG	35;35;36	G;C;G	35;35;36	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	L231V	NONSYN	691	693	CTT	850	852	GTT	19;19;19	G,A;T;T	17,1;19;18	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1746	16.5	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1012	1012	C	28	C	28	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	360	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1771	15.2	0	.	p	.	0	V12trunc	TRUNC	34	34	G	302	302	G	13	G	13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	360	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1771	15.2	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	359	361	CAG	10;10;10	C;A;G	10;10;10	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	360	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1771	15.2	0	.	p	.	0	T83I	NONSYN	247	249	ACC	509	511	ATC	15;16;14	A;T;C	15;16;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	360	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1771	15.2	0	.	p	.	0	I99M	NONSYN	295	297	ATA	557	559	ATG	14;14;14	A;T;G	14;14;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	360	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1771	15.2	0	.	p	.	0	A130T	NONSYN	388	390	GCC	650	652	ACC	19;18;19	A;C;C	19;18;19	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	360	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1771	15.2	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1031	1033	ACG	20;20;19	A;C;G	20;20;19	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1322	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3551	27.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1988	1990	ACC	28;28;28	A;C;C	28;28;28	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1322	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3551	27.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2381	2383	CAA	29;29;29	C;A;A	28;28;28	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1322	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3551	27.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2549	2551	ATT	25;25;25	A;T;T	25;25;25	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1322	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3551	27.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2633	2635	GTT	29;29;28	G;T;T	29;29;28	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1322	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3551	27.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2741	2743	GAG	19;20;20	G;A;G	19;20;20	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1322	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3551	27.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2969	2971	ATG	37;37;36	A;T;G	37;37;36	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1322	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3551	27.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3104	3106	GAT	35;34;34	G;A;T	34;34;34	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1196	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3658	24.7	0	.	p	.	0	I46M	NONSYN	136	138	ATC	400	402	ATG	9;9;9	A;T;G	6;8;6	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1196	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3658	24.7	0	.	p	.	0	V208I	NONSYN	622	624	GTC	886	888	ATC	35;37;37	A;T;C	35;36;37	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1196	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3658	24.7	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3202	3204	CAC	16;15;15	C;A;C	16;14;15	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1196	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3658	24.7	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3205	3207	CTC	15;15;15	C;T;C	15;15;15	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	520	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1831	21.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	103	105	GAA	14;13;13	G;A;A	14;13;13	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	520	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1831	21.4	0	.	p	.	0	T226A	NONSYN	676	678	ACG	772	774	GCG	20;20;19	G;C;G	19;17;17	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	520	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1831	21.4	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1114	1116	ATC	19;19;19	A;T;C	19;19;19	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	520	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1831	21.4	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1417	1419	TTT	24;24;22	T;T;T	24;24;22	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	500	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1857	20.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1212	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3640	25.0	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1213	1215	ACC	26;26;24	A;C;C	26;26;24	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1212	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3640	25.0	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2455	2457	GAC	29;30;31	G;A;C	29;30;31	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	440	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.1	1578	17.3	0	.	p	.	0	V200I	NONSYN	598	600	GTC	756	758	ATC	22;23;23	A;T,C;C	22;21,2;23	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	440	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	342	13.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	164	166	GGA	8;8;8	G;G;A	8;8;8	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	474	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1691	21.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	643	645	TGT	30;29;29	T;G;T	30;29;29	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	474	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1691	21.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1213	1215	TTG	21;21;21	T;T;G	21;21;21	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	474	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1691	21.1	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1423	1425	ACG	7;7;8	A;C;G	7;7;8	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	546	mdtL	1176	1176	98.3	mdtL.l6.c30.ctg.1	1904	21.6	0	.	p	.	0	A185S	NONSYN	553	555	GCC	936	938	TCC	19;19;18	T;C;C	19;19;18	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	476	mdtN	1032	1032	98.02	mdtN.l15.c30.ctg.1	1725	20.7	0	.	p	.	0	V119I	NONSYN	355	357	GTT	713	715	ATT	32;30;30	A;T;T	32;30;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	280	282	ATG	14;13;14	A;T;G	14;13;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	346	348	ATC	16;16;17	A;T;C	16;16;17	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	595	597	CGC	21;21;21	C;G;C	21;21;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	961	963	AGC	18;18;19	A;G;C	18;18;19	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1162	1164	GTG	20;19;18	G;T;G	20;19;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1225	1227	AAC	21;21;21	A;A;C	20;18;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1270	1272	GTC	18;18;20	G;T;C	18;17;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1300	1302	ATA	21;21;22	A;T;A	21;21;22	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1408	1410	TCT	27;26;25	T;C;T	27;26;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1795	1797	GCG	29;30;31	G;C;G	29;29;30	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	796	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2633	22.6	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2008	2010	ATC	24;24;23	A;T;C	24;24;22	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	508	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.7	0	.	p	.	0	S129A	NONSYN	385	387	TCA	672	674	GCG	25;25;25	G;C;G	25;25;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	508	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.7	0	.	p	.	0	A187T	NONSYN	559	561	GCC	846	848	ACC	27;27;27	A;C;C	27;27;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	508	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.7	0	.	p	.	0	H211R	NONSYN	631	633	CAC	918	920	CGC	29;28;29	C;G;C	29;28;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	508	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.7	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1035	1037	GCT	23;23;23	G;C;T	23;23;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	508	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.7	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1119	1121	AAA	12;15;15	A;A;A	12;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	508	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.7	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1137	1139	CGA	17;18;18	C;G;A	17;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	508	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.7	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1302	1304	GCC	17;16;18	G;C;C	17;16;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	508	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.7	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1314	1316	GAT	17;19;20	G;A;T	17;19;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	508	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.7	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1731	1733	GCT	10;10;10	G;C;T	10;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1350	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3926	25.8	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1603	1605	AAG	21;18;17	A;A;G	21;18;17	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1350	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3926	25.8	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2680	2682	CTG	28;28;28	C;T;G	27;28;28	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	108	mgrB	144	144	100.0	mgrB.l6.c4.ctg.1	673	11.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	644	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2241	21.7	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1047	1049	AAC	17;17;17	A;A;C	17;17;17	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	644	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2241	21.7	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1593	1595	ATA	30;30;29	A;T;A	29;29;29	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	544	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1754	23.5	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1404	1406	GAT	33;31;31	G;A;T	33;31;31	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	544	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1754	23.5	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1407	1409	CTG	31;30;30	C;T;G	31;30;30	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	379	98.68	nfsA.l15.c4.ctg.1	1018	21.2	0	.	p	.	0	R27C	NONSYN	79	81	CGT	373	375	TGT	23;24;25	T;G;T	23;24;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	379	98.68	nfsA.l15.c4.ctg.1	1018	21.2	0	.	p	.	0	I117T	NONSYN	349	351	ATC	643	645	ACC	45;45;42	A;C;C	45;45;42	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	379	98.68	nfsA.l15.c4.ctg.1	1018	21.2	1	SNP	p	R15C	0	.	.	43	45	CGC	337	339	CGC	23;23;21	C;G;C	23;23;21	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	379	98.68	nfsA.l15.c4.ctg.1	1018	21.2	1	SNP	p	S33R	0	.	.	97	99	AGC	391	393	AGC	34;34;34	A;G;C	34;34;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	1033	16.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	622	624	GAC	27;27;27	G;A;C	27;26;27	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	1033	16.0	1	SNP	p	G131D	0	.	.	391	393	GGC	454	456	GGC	23;24;24	G;G;C	23;24;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	1033	16.0	1	SNP	p	R203C	0	.	.	607	609	CGT	670	672	CGT	27;28;28	C;G;T	26;28;27	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	1033	16.0	1	SNP	p	R203L	0	.	.	607	609	CGT	670	672	CGT	27;28;28	C;G;T	26;28;27	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	490	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1744	21.0	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1222	1224	GAG	23;24;24	G;A;G	23;24;24	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	490	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1744	21.0	1	SNP	p	G141E	0	.	.	421	423	GGT	709	711	GGT	38;38;39	G;G;T	38;38;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	490	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1744	21.0	1	SNP	p	G141D	0	.	.	421	423	GGT	709	711	GGT	38;38;39	G;G;T	38;38;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	490	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1744	21.0	1	SNP	p	R154A	0	.	.	460	462	CGT	748	750	CGT	37;37;37	C;G;T	37;37;37	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	490	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1744	21.0	1	SNP	p	R154D	0	.	.	460	462	CGT	748	750	CGT	37;37;37	C;G;T	37;37;37	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	936	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2863	24.6	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1935	1937	GTG	34;36;36	G;T;G	34;36;36	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	936	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2863	24.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1962	1964	TCG	34;36;37	T;C;G	31;35;37	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	936	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2863	24.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2577	2579	AAC	20;20;21	A;A;C	20;20;21	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	936	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2863	24.6	1	SNP	p	A85T	0	.	.	253	255	GCG	591	593	GCG	20;19;20	G;C;G	19;18;19	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	936	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2863	24.6	1	SNP	p	D111H	0	.	.	331	333	GAT	669	671	GAT	19;19;19	G;A;T	18;18;18	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	936	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2863	24.6	1	SNP	p	S129P	0	.	.	385	387	TCC	723	725	TCC	24;23;23	T;C;C	24;23;23	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	632	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2542	18.7	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1740	1742	AAC	23;25;24	A;A;C	23;25;24	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	632	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2542	18.7	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1749	1751	GAT	23;24;24	G;A;T	23;24;24	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	566	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2073	20.6	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	912	914	CAG	19;19;19	C;A;G	19;19;19	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	566	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2073	20.6	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1386	1388	GAT	29;29;30	G;A;T	29;27;30	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	V146F	0	.	.	436	438	GTT	684	686	GTT	33;33;31	G;T;T	33;33;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1785	1787	CAG	31;31;31	C;A;G	31;31;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1785	1787	CAG	31;31;31	C;A;G	31;31;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1824	1826	CAC	23;24;23	C;A;C	23;24;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1833	1835	CGT	25;25;24	C;G;T	25;25;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1833	1835	CGT	25;25;24	C;G;T	25;25;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1839	1841	TCC	24;23;23	T;C;C	24;23;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1845	1847	CTC	23;23;24	C;T;C	23;23;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1935	1937	ACC	36;37;37	A;C;C	36;37;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1938	1940	CCT	36;35;34	C;C;T	36;35;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1640	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4614	26.8	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2307	2309	CGT	44;43;43	C;G;T	44;43;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	.	n	.	0	A226G	SNP	226	226	A	353	353	G	256	G,A	254,2	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	1	SNP	n	A794G	0	.	.	794	794	A	921	921	A	228	A	226	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	1	SNP	n	A794T	0	.	.	794	794	A	921	921	A	228	A	226	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	1	SNP	n	G926C	0	.	.	926	926	G	1053	1053	G	252	G,C	249,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	1	SNP	n	G926A	0	.	.	926	926	G	1053	1053	G	252	G,C	249,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	1	SNP	n	G926T	0	.	.	926	926	G	1053	1053	G	252	G,C	249,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	1646	1646	A	201	A	198	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	1646	1646	A	201	A	198	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	1646	1646	A	201	A	198	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	C194T	.	194	194	C	321	321	C	243	C,T	175,67	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	A250T	.	250	250	A	377	377	A	242	A,T	183,57	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	G1002A	.	1002	1002	G	1129	1129	G	217	G,A	131,84	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	G474A	.	474	474	G	601	601	G	248	G,A	183,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	G1006C	.	1006	1006	G	1133	1133	G	217	G,C	133,82	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	A79G	.	79	79	A	206	206	A	241	A,G	172,63	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	C719T	.	719	719	C	846	846	C	277	C,T	167,105	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	T273A	.	273	273	T	400	400	T	253	T,A	183,67	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	T1010C	.	1010	1010	T	1137	1137	T	213	T,C	128,80	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	C1038T	.	1038	1038	C	1165	1165	C	225	C,T	138,86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	C183T	.	183	183	C	310	310	C	222	C,T	141,79	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	T90C	.	90	90	T	217	217	T	221	T,C	164,55	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5546	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1951	207.4	0	HET	.	.	.	A253T	.	253	253	A	380	380	A	241	A,T	182,58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	262	sat_1	525	525	100.0	sat_1.l6.c30.ctg.1	1093	18.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	382	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1080	26.4	1	SNP	p	R20H	0	.	.	58	60	CGC	403	405	CGC	57;58;58	C;G;C	56;58;58	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	382	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1080	26.4	1	SNP	p	G121D	0	.	.	361	363	GGT	706	708	GGT	27;27;27	G;G;T	27;27;27	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	206	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	888	17.1	1	SNP	p	A12S	0	.	.	34	36	GCA	309	311	GCA	38;38;40	G;C;A	38;38;40	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	628	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2064	23.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
